Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study
- 28 July 2005
- Vol. 113 (7-8), 550-554
- https://doi.org/10.1111/j.1600-0463.2005.apm_151.x
Abstract
Micropapillary carcinoma has been described in various organs, including the breast, urinary bladder, ovary and lung. We here present a case of pulmonary micropapillary carcinoma in a 72‐year‐old Japanese man who died of respiratory failure and septic shock, following which autopsy was performed. A mass measuring 2.5×2.5×2.5 cm was observed in the left lower lobe of the lung. The tumor showed moderately differentiated papillary adenocarcinoma with a focal micropapillary component. Carcinomatous lymphangiosis was also observed in the left lung and metastatic lesions were observed in the bilateral lung, liver, vertebra, muscle layer of the urinary bladder, right adrenal gland, spleen and lymph nodes. The micropapillary component was predominant at some metastatic sites. Immunohistochemically, both the adenocarcinoma and micropapillary components were positive for cytokeratin (CK) 7, CK19, TTF (thyroid transcription factor)‐1, carcinoembryonic antigen (CEA) and surfactant apoprotein A (SP‐A), and negative for CK20, estrogen receptor, progesterone receptor, uroplakin III, and CA125. The invasive area of the conventional adenocarcinoma component contained a large number of myofibroblasts, whereas the stroma of the micropapillary component contained a small number of myofibroblasts. However, no myofibroblasts were observed in the stroma of the central core of the non‐invasive micropapillary carcinoma. Several lymphatic invasions by neoplastic cells were identified in the peripheral area of the micropapillary component using D2–40 antibody. The immunohistochemical profile may be helpful in determining the primary location of the neoplasm containing micropapillary features. Myofibroblasts are present in the stroma of the invasive neoplastic nests in the micropapillary component as well as the conventional adenocarcinoma component, and D2–40 monoclonal antibody may be useful for evaluating the lymphatic invasion of pulmonary micropapillary carcinoma.Keywords
This publication has 16 references indexed in Scilit:
- Micropapillary clusters in early-stage lung adenocarcinomasCancer, 2004
- Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary featuresAnnals of Diagnostic Pathology, 2003
- Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of AngiosarcomasLaboratory Investigation, 2002
- Micropapillary Component in Lung AdenocarcinomaThe American Journal of Surgical Pathology, 2002
- Clinicopathologic Analysis of Invasive Micropapillary Differentiation in Breast CarcinomaLaboratory Investigation, 2001
- Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54Pathology - Research and Practice, 2000
- CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF MICROPAPILLARY TRANSITIONAL CELL CARCINOMA:Journal of Urology, 2000
- Ovarian Serous Borderline Tumors with Micropapillary and Cribriform PatternsThe American Journal of Surgical Pathology, 1999
- Micropapillary Serous Carcinoma of the OvaryThe American Journal of Surgical Pathology, 1996
- Micropapillary Variant of Transitional Cell Carcinoma of the Urinary Bladder Histologic Pattern Resembling Ovarian Papillary Serous CarcinomaThe American Journal of Surgical Pathology, 1994